New
Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
WDNA ETF · WisdomTree BioRevolution UCITS ETF
The WDNA Exchange Traded Fund (ETF) is provided by WisdomTree. It is built to track an index: WisdomTree BioRevolution ESG Screened Index. The WDNA ETF provides physical exposure, so by buying it you actually own parts of all the 83 underlying holdings. The dividend policy is capitalization.
Last update 3/13/2026, 8:00 AM UTC
LIVE
CLOSED
This fund is part ofDeveloped Market Blended Cap1M perf.-3.95%
Last price
$19.33
1M perf.
-1.01%
1M flows
N/A
AuM
€9.2M
E/R
0.45%
Rating
ESG Consensus®
WDNA
$19.33
Performance & flows
Segment for quartile rank
December 12, 2025 → March 12, 2026
Create a free account to view the flows graph
WDNA
$19.56
+2.66%
Developed Market Blended Cap
-0.52%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -1.01%  | +2.66%  | +33.98% | +8.80%  | N/A | -5.79% | +2.66% | +2.66% | |
| Flows |
Key fund info
Segment for quartile rank
Main characteristics
More details
NAV
3/12/2026
$19.56
1D NAV change
-2.68%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
83
Inception date
12/3/2021
Jurisdiction
Ireland
Distribution
Luxembourg
Ireland
United Kingdom
Germany
France
Legal structure
Irish Collective Asset-management Vehicle
Base currency
USD
Classification
Product type
Benchmark
WisdomTree BioRevolution ESG Screened Index
Asset class
Factors
N/A
Investment strategy
The WisdomTree BioRevolution UCITS ETF (the “Fund”) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution ESG Screened Index (the "Index").
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs
WDNA
1M perf.
-3.53%
E/R
0.45%
GNOM
1M perf.
-5.57%
E/R
0.5%
GNOG
1M perf.
-5.61%
E/R
0.5%
DOCG
1M perf.
-7.52%
E/R
0.49%
HTEC
1M perf.
-4.76%
E/R
0.8%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | +2.66% | +33.98% | +8.80% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
1
2
3
4
5
6
7
PRIIPS
1
2
3
4
5
6
7
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
83.62%
Switzerland
4.85%
Denmark
4.09%
Germany
1.59%
Netherlands
1.34%
Bermuda
1.15%
United Kingdom
1.06%
Japan
1.01%
Unavailable
0.78%
Other
0.50%
Sectors
Health Care
79.01%
Materials
3.41%
Consumer Staples
1.59%
Energy
1.01%
Unavailable
14.99%
Diversification
Total weight of top 15 holdings out of 83
Top 15 holdings
Data as of January 31, 2026
MODERNA INC
US86366E1064
LILLY
JOHNSON&JOHNSON
NATERA
BIONTECH SE ADR
STOKE THERAPEUTICS INC
PFIZER
Create a free account to view top holdings
DK0062498333
BEAM THERAPEUTICS
AMGEN-T
IONIS PHARMACEUTICALS INC
UTD THERAPEUT
IMMUNOME
US0463531089
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
Yes
SDG
ESG Consensus® by Conser
Data as of December 31, 2025
MethodologyOur partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about WDNA ETF's sustainability, based on their methodology.
ESG Consensus®
ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.
WDNA’s has a Final Sustainability Grade of either A+, A, or A-.
A+
A
A-
B+
B
B-
C+
C
C-
D
This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight EnterpriseHoldings review
91.00% of holdings have positive scoring
9.79% of holdings have negative scoring
13.69%
58.64%
18.68%
5.79%
Consensus levels
Strong
Medium
Weak
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
WisdomTree BioRevolution ESG Screened Net Return Index - USD
Index ticker
WTEDNAN Index
Index dividend policy
NTR
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
WisdomTree
WisdomTree ID Card
Number of funds
429
Total AuM
€133.29B
Expense ratio range
0.05% - 4.32%
Average expense ratio
0.5435%
Top 5 funds by WisdomTree
| AuM | ||
|---|---|---|
USFR | WisdomTree Floating Rate Treasury Fund | €14.11B |
DGRW | WisdomTree U.S. Quality Dividend Growth Fund | €13.51B |
PHAU | WisdomTree Physical Gold ETC | €7.79B |
DXJ | WisdomTree Japan Hedged Equity Fund | €5.24B |
SGBS | WisdomTree Physical Swiss Gold ETC | €5.04B |
Frequently asked questions about WDNA
What does WisdomTree BioRevolution UCITS ETF, WDNA, invest in?
WDNA is a Passive ETF. This ETF provides exposure to Equally Weighted Developed markets Equities.
Which benchmark or index does WDNA replicate?
WDNA tracks the WisdomTree BioRevolution ESG Screened Net Return Index - USD, through a optimized sampling replication method.
What is the Total Expense ratio (TER) of WDNA?
WDNA carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.
When was WDNA launched?
WDNA was introduced to the market on December 3, 2021. It trades on Luxembourg, among other exchanges
Who is the ETF issuer of WDNA?
WisdomTree BioRevolution UCITS ETF, WDNA, is provided by WisdomTree. Learn more about WisdomTree here.
What is the current assets under management (AUM) of WDNA?
WDNA oversees €9.2M in assets as of March 12, 2026.
How has WDNA performed lately?
Based on data from March 12, 2026, WDNA returned -1.01% over the past month, 2.66% over the last three months and 2.66% year-to-date.
What are the latest inflows or outflows for WDNA?
As of March 12, 2026, WDNA recorded net flows of +€888K year-to-date.
Does WDNA distribute dividends?
WDNA follows a capitalizing, meaning it reinvests income within the fund.
What are the main country or region exposures of WDNA?
As of January 31, 2026, WDNA has significant geographic allocations in USA, Switzerland and Denmark.
In which sector or theme does WDNA invest in?
As of January 31, 2026, WDNA focuses largely on Health Care, Materials and Consumer Staples.
How many securities does WDNA hold and how diversified is it?
As of January 31, 2026, WDNA holds 83 positions in its portfolio, with 38.57% of assets concentrated in its top 15 holdings.
What are the main positions in WDNA?
As of January 31, 2026, WDNA top three holdings include MODERNA INC, US86366E1064 and LILLY.
What is the base currency of WDNA?
The base currency of WDNA is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
